Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-19 Purchase | 2022-05-19 4:50 pm | EXICURE INC. | XCUR | Muralidhar Bali Director | 1,472,126 | $0.1937 | $285,151 | 8,449,126 (Indirect) | View |
| 2021-07-14 Purchase | 2021-07-15 5:34 pm | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 111,736 | $8.5 | $949,756 | 2,073,957 (Indirect) | View |
| 2021-06-23 Purchase | 2021-06-25 09:00 am | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 20,710 | $9.2827 | $192,245 | 1,962,221 (Indirect) | View |
| 2021-06-21 Purchase | 2021-06-23 08:33 am | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 47,274 | $8.9354 | $422,414 | 1,941,511 (Indirect) | View |
| 2021-06-08 Purchase | 2021-06-10 09:00 am | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 16,605 | $9.4977 | $157,709 | 1,894,237 (Indirect) | View |
| 2021-06-03 Purchase | 2021-06-07 08:53 am | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 12,357 | $9.2551 | $114,365 | 1,877,632 (Indirect) | View |
| 2021-05-28 Purchase | 2021-06-02 10:37 am | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 14 | $9.5 | $133 | 1,865,275 (Indirect) | View |
| 2021-05-26 Purchase | 2021-05-28 4:10 pm | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 7,035 | $9.3624 | $65,864 | 1,865,261 (Indirect) | View |
| 2021-04-13 Purchase | 2021-04-15 4:15 pm | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 200,000 | $15 | $3,000,000 | 1,858,226 (Indirect) | View |
| 2020-10-14 Purchase | 2020-10-16 12:24 pm | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 200,000 | $15 | $3,000,000 | 1,792,518 (Indirect) | View |
| 2019-12-19 Purchase | 2019-12-23 4:05 pm | EXICURE INC. | XCUR | Muralidhar Bali Director | 727,000 | $2.75 | $1,999,250 | 6,977,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-06 Option Award | 2023-06-08 6:14 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 5:38 pm | N/A 2033-05-24 | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 4:17 pm | N/A 2032-06-12 | EXICURE INC. | XCUR | Muralidhar Bali Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:15 pm | N/A 2032-05-24 | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:17 pm | N/A 2031-06-01 | EXICURE INC. | XCUR | Muralidhar Bali Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 9:08 pm | N/A 2031-05-19 | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-04-13 Conversion | 2021-04-15 4:15 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 9,078,458 | $0 | 1,858,226 (Indirect) | View |
| 2021-04-08 Option Award | 2021-04-12 3:09 pm | N/A 2031-04-07 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 14,000 | $0 | 14,000 (Direct) | View |
Ownership | 2021-04-08 5:03 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 0 | $0 | 1,658,226 (Indirect) | View |
| 2020-10-14 Conversion | 2020-10-16 12:24 pm | N/A N/A | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 12,009,184 | $0 | 1,792,518 (Indirect) | View |
Ownership | 2020-10-08 9:06 pm | N/A N/A | SPRUCE BIOSCIENCES INC. | SPRB | Muralidhar Bali Director | 0 | $0 | 1,592,518 (Indirect) | View |
| 2020-06-04 Option Award | 2020-06-09 4:27 pm | N/A 2030-06-03 | EXICURE INC. | XCUR | Muralidhar Bali Director | 21,693 | $0 | 21,693 (Direct) | View |
| 2019-08-02 Option Award | 2019-08-05 4:18 pm | N/A 2029-08-01 | EXICURE INC. | XCUR | Muralidhar Bali Director | 43,386 | $0 | 43,386 (Direct) | View |
Ownership | 2019-08-05 4:12 pm | N/A N/A | EXICURE INC. | XCUR | Muralidhar Bali Director | 0 | $0 | 6,250,000 (Indirect) | View |